Back to Browse Journals » Risk Management and Healthcare Policy » Volume 4

Ensuring safe access to medication for palliative care while preventing prescription drug abuse: innovations for American inner cities, rural areas, and communities overwhelmed by addiction

Authors Francoeur RB

Published 6 September 2011 Volume 2011:4 Pages 97—105

DOI http://dx.doi.org/10.2147/RMHP.S24068

Review by Single-blind

Peer reviewer comments 2

Richard B Francoeur
School of Social Work, Adelphi University, Garden City, NY, USA; Center for the Psychosocial Study of Health and Illness, Columbia University, New York, NY, USA

Abstract: This article proposes and develops novel components of community-oriented programs for creating and affording access to safe medication dispensing centers in existing retail pharmacies and in permanent or travelling pharmacy clinics that are guarded by assigned or off-duty police officers. Pharmacists at these centers would work with police, medical providers, social workers, hospital administrators, and other professionals in: planning and overseeing the safe storage of controlled substance medications in off-site community safe-deposit boxes; strengthening communication and cooperation with the prescribing medical provider; assisting the prescribing medical provider in patient monitoring (checking the state prescription registry, providing pill counts and urine samples); expanding access to lower-cost, and in some cases, abuse-resistant formulations of controlled substance medications; improving transportation access for underserved patients and caregivers to obtain prescriptions; and integrating community agencies and social networks as resources for patient support and monitoring. Novel components of two related community-oriented programs, which may be hosted outside of safe medication dispensing centers, are also suggested and described: (1) developing medication purchasing cooperatives (ie, to help patients, families, and health institutions afford the costs of medications, including tamper- or abuse-resistant/deterrent drug formulations); and (2) expanding the role of inner-city methadone maintenance treatment programs in palliative care (ie, to provide additional patient monitoring from a second treatment team focusing on narcotics addiction, and potentially, to serve as an untapped source of opioid medication for pain that is less subject to abuse, misuse, or diversion).

Keywords: controlled substances, diversion, drug abuse, inner-city, methadone, methadone maintenance treatment, pain, palliative care, pharmacy, prescription drugs, rural, safety, tamper- and abuse-resistant drugs, TARD, transportation

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] View Full Text [HTML] 

 

Readers of this article also read:

Advances in cancer pain from bone metastasis

Zhu XC, Zhang JL, Ge CT, Yu YY, Wang P, Yuan TF, Fu CY

Drug Design, Development and Therapy 2015, 9:4239-4245

Published Date: 18 August 2015

Patient risk factors for developing a drug-related problem in a cardiology ward

Urbina O, Ferrández O, Luque S, Grau S, Mojal S, Pellicer R, Riu M, Salas E, Comin-Colet J

Therapeutics and Clinical Risk Management 2015, 11:9-15

Published Date: 17 December 2014

Analgesia for pain during subcutaneous injection: effectiveness of manual pressure application before injection

Nakashima Y, Harada M, Okayama M, Kajii E

International Journal of General Medicine 2013, 6:817-820

Published Date: 25 September 2013

Optimal management of equine keratomycosis

Galera PD, Brooks DE

Veterinary Medicine: Research and Reports 2012, 3:7-17

Published Date: 15 March 2012